ISS [iSoftStone] SC 13D/A: (Original Filing)

[1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Pine River Capital Management L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [x] 3. SEC USE ONLY 4. SOURCE OF FUNDS WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 6. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF]

ISS [iSoftStone] SC 13D/A: 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.

[1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Pine River Capital Management L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [x] 3. SEC USE ONLY 4. SOURCE OF FUNDS WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 6. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF]

CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[CUSIP No. 16938C106 13D 1 Essence International Investment Limited NAMES OF REPORTING PERSONS: N/A I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS WC 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands NUMBER OF SHARES BENEFICIALLY]

CBPO [China Biologic Products] SC 13D/A: CUSIP No. 16938C106 13D 1 Essence International Investment

[CUSIP No. 16938C106 13D 1 Essence International Investment Limited NAMES OF REPORTING PERSONS: N/A I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS WC 5 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands NUMBER OF SHARES BENEFICIALLY]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G: (Original Filing)

[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities that]

By | 2016-03-27T15:52:29+00:00 July 17th, 2014|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G: reporting person’s initial filing on this form with

[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities that]

By | 2016-03-27T15:53:49+00:00 July 17th, 2014|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] S-8: (Original Filing)

[Registration No. 333- FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue, Xianyang, Shaanxi Province, People’s Republic of China 712046 Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (Full title of the plan) Ronghua Wang President and Chief] [BIOSTAR PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN, INC. ______________________ Section 1. Purpose. The purpose of the Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (the “Plan”) is to attract and retain outstanding individuals as Key Employees, Directors and Consultants of the Company and its Subsidiaries, to recognize the contributions made to the Company and its Subsidiaries by Key Employees, Directors and] [[Schiff Hardin LLP Letterhead] July 17, 2014 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: EX-5.1 3 ex5-1.htm EX-5.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated March 31, 2014 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K]

By | 2016-03-28T18:27:41+00:00 July 17th, 2014|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] S-8: Registration No. 333- FORM S-8 REGISTRATION STATEMENT UNDER

[Registration No. 333- FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue, Xianyang, Shaanxi Province, People’s Republic of China 712046 Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (Full title of the plan) Ronghua Wang President and Chief] [BIOSTAR PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN, INC. ______________________ Section 1. Purpose. The purpose of the Biostar Pharmaceuticals, Inc. 2013 Equity Incentive Plan (the “Plan”) is to attract and retain outstanding individuals as Key Employees, Directors and Consultants of the Company and its Subsidiaries, to recognize the contributions made to the Company and its Subsidiaries by Key Employees, Directors and] [[Schiff Hardin LLP Letterhead] July 17, 2014 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: EX-5.1 3 ex5-1.htm EX-5.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated March 31, 2014 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K]

By | 2016-03-28T18:28:59+00:00 July 17th, 2014|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar